SPAIN | ACTIS
06/11/2019
Lmite 12 Mar 2021
Oferta Tecnolgica
Ref.
TODE20200302001
Mas-related gene X2 receptor antagonists
A German university offers a new drug target for inflammatory and other diseases related to the mas-related gene X2 (MRGX2) receptor. It will find application in treating pain conditions that involve mast cells, such as skin itching and pain. Related illnesses may be included. Industrial partners are sought for license agreements.
Socios

logotipo CEOE Aragnlogotipo ITAINNOVAlogotipo Cmara Toledologotipo FEDAlogotipo UCLM
logotipo FUNDECYT-PCTEX logotipo ADERlogotipo FERlogotipo AINlogotipo UNAV

06/11/2019

Requerimientos: IE 6.0+, FF 1.5+ 1024x768+ | Aviso Legal | Confidencialidad

06/11/2019